C. Thierry

发表

Modulation of human T lymphocyte functions by isoprinosine.

D. Cupissol, B. Serrou, A. Rey, 1983, International journal of immunopharmacology.

Differences in mitogen response and electrophoretic mobility of two T-lymphocyte sub-populations.

P. Chollet, J. Chassagne, B. Sauvezie, 1977, European journal of cancer.

Routine technique of lymphocyte cryopreservation evaluated by in vitro tests of immune response.

H. Vallés, B. Serrou, J. Turc, 1977, European journal of cancer.

Poor Immune Response to Rabies Post-Exposure Prophylaxis: An Attempt to Understand the Underlying Mechanisms

B. Genton, R. Zanoni, R. Audran, 2016 .

Human autologous rosettes. I. Mechanism of binding of autologous erythrocytes by T cells.

B. Serrou, J. Caraux, R. Lodise, 1979, Cellular immunology.

Mouse red cell rosette formation by subpopulations of human lymphocytes.

J. Bertoglio, J. Doré, C. Thierry, 1977, Clinical and experimental immunology.

Quantitative comparison of K cell potential in human T and null cells

S. Weisbroth, F. Loor, B. Serrou, 1978, European journal of immunology.

Human lymphocyte subpopulations: effects of glucocorticoids in vitro.

D. Duval, B. Serrou, F. Homo, 1979, Journal of steroid biochemistry.

Human autologous rosettes. II. Further characterization: markers and functions.

J. Dufer, A. Desplaces, D. Zagury, 1981, Cellular immunology.

Solubilization of a human lymphocyte factor for autorosette.

I. Stefas, B. Serrou, M. Rucheton, 1984, Cellular immunology.

Human autologous rosettes. IV. Their relation with interleukin 2 activity production and natural killer cells in cancer patients.

B. Klein, B Klein, D Zagury, 1984, Cellular immunology.

Human autologous rosettes. II. Prognostic significance of variations in autologous rosette-forming cells in the peripheral blood of cancer patients.

B. Serrou, J. Caraux, C. Thierry, 1979, Journal of the National Cancer Institute.

Diminished interleukin-2 activity production in cancer patients bearing solid tumors and its relationship with natural killer cells.

B. Klein, D. Zagury, B. Serrou, 1983, Immunology letters.

Immune complexes in patients bearing solid tumors.

D. Cupissol, B. Serrou, C. Thierry, 1985, Contemporary topics in immunobiology.

Regulation of human suppressor cell function by thymosin.

A. Goldstein, B. Serrou, J. Caraux, 1979, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Autorosette-forming cells: Further characterization and immunopharmacology

B. Serrou, A. Rey, J. Caraux, 1981 .

Ability of thymosin to decrease in vivo and in vitro suppressor cell activity in tumor bearing mice and cancer patients.

A. Goldstein, D. Cupissol, C. Rosenfeld, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

THYMOSIN MODULATION OF SUPPRESSOR FUNCTION IN MICE AND MAN 1

A. Goldstein, D. Cupissol, C. Rosenfeld, 1979, Annals of the New York Academy of Sciences.

Electrophoretic mobility of peripheral non-B human Fc gamma-receptors bearing lymphocytes.

P. Chollet, H. Gauvin, J. Chassagne, 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Isolation and electrophoretic mobility of three lymphoid populations in normal human blood.

P. Chollet, J. Chassagne, B. Sauvezie, 1977, European journal of cancer.

Immune imbalance in cancer patients.

D. Cupissol, B. Serrou, J. Caraux, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

T‐LYMPHOCYTE MATURATION AND ANTITUMORAL EFFECT OF A THYMIC EXTRACT OBTAINED FROM A STIMULATED MODEL

T. Rème, B. Delor, J. Dubois, 1975, Annals of the New York Academy of Sciences.

Human K cell activity. I. Relation to effector cells buoyant density.

B. Serrou, J. Caraux, C. Thierry, 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.].